MY160723A - An anticoagulant - Google Patents

An anticoagulant

Info

Publication number
MY160723A
MY160723A MYPI2013702580A MYPI2013702580A MY160723A MY 160723 A MY160723 A MY 160723A MY PI2013702580 A MYPI2013702580 A MY PI2013702580A MY PI2013702580 A MYPI2013702580 A MY PI2013702580A MY 160723 A MY160723 A MY 160723A
Authority
MY
Malaysia
Prior art keywords
anticoagulant
edta
illustrative
phosphate buffer
trisodium citrate
Prior art date
Application number
MYPI2013702580A
Inventor
Abdullah Maha
Chou Min Chong
Nor Shamsudin Mariana
Md Yusoff Fatimah
Than Thian Lung Leslie
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI2013702580A priority Critical patent/MY160723A/en
Priority to CN201480072604.5A priority patent/CN105899203A/en
Priority to PCT/MY2014/050018 priority patent/WO2015102482A1/en
Priority to JP2016561987A priority patent/JP2017503023A/en
Publication of MY160723A publication Critical patent/MY160723A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE PRESENT INVENTION RELATES TO AN ANTICOAGULANT COMPOSITION. PARTICULARLY, THE ANTICOAGULANT IS ABLE TO PREVENT COAGULATION OF FISH BLOOD EFFECTIVELY. THE ANTICOAGULANT COMPRISES OF POTASSIUM CHLORIDE, SODIUM CHLORIDE, EDTA, TRISODIUM CITRATE DEHYDRATE AND PHOSPHATE BUFFER. MOST ILLUSTRATIVE
MYPI2013702580A 2013-12-30 2013-12-30 An anticoagulant MY160723A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MYPI2013702580A MY160723A (en) 2013-12-30 2013-12-30 An anticoagulant
CN201480072604.5A CN105899203A (en) 2013-12-30 2014-12-23 An anticoagulant
PCT/MY2014/050018 WO2015102482A1 (en) 2013-12-30 2014-12-23 An anticoagulant
JP2016561987A JP2017503023A (en) 2013-12-30 2014-12-23 Anticoagulant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013702580A MY160723A (en) 2013-12-30 2013-12-30 An anticoagulant

Publications (1)

Publication Number Publication Date
MY160723A true MY160723A (en) 2017-03-15

Family

ID=53493738

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013702580A MY160723A (en) 2013-12-30 2013-12-30 An anticoagulant

Country Status (4)

Country Link
JP (1) JP2017503023A (en)
CN (1) CN105899203A (en)
MY (1) MY160723A (en)
WO (1) WO2015102482A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107988140B (en) * 2018-01-25 2021-02-02 鲁东大学 Abalone blood cell anticoagulant protective agent and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150403C (en) * 1983-07-15 1987-07-13 Radiometer As BLOOD SAMPLING EQUIPMENT
FR2642065B1 (en) * 1989-01-24 1991-05-24 Lipha DERIVATIVES OF ALCOHANIC BENZOCYCLOALCENYL DIHYDROXY ACIDS, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM
JPH0695092B2 (en) * 1989-10-30 1994-11-24 隆己 永田 Anticoagulant for blood cell counting
US6245885B1 (en) * 1998-10-05 2001-06-12 Mcgill University Bax-mediated apoptosis modulating reagents and methods
JP2003048889A (en) * 2001-08-01 2003-02-21 Ajinomoto Co Inc Novel nucleic acid-based compound
DE602006019731D1 (en) * 2005-06-09 2011-03-03 Ucb Pharma Sa 2,6-CHINOLINE DERIVATIVES AND METHOD FOR THEIR PREPARATION AND USE AS MEDICAMENTS
WO2008078344A1 (en) * 2006-12-22 2008-07-03 Humanitas Mirasole S.P.A. A method for measuring plasma levels of long pentraxin ptx3
CN103323296A (en) * 2012-03-23 2013-09-25 南京柯伦迪检测技术有限公司 Anticoagulant agent match use method for blood platelet function detection

Also Published As

Publication number Publication date
CN105899203A (en) 2016-08-24
WO2015102482A1 (en) 2015-07-09
JP2017503023A (en) 2017-01-26

Similar Documents

Publication Publication Date Title
PH12020551397A1 (en) Cot modulators and methods of use thereof
MX363981B (en) A low sodium salt composition.
TN2015000423A1 (en) Variants of tissue inhibitor of metalloproteinase type three (tipm-3), compositions and methods
EA201592074A1 (en) COMPOSITIONS AND METHODS OF CHANGING THE SIGNAL SYSTEM OF THE SECONDARY MESSENGER
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
TR201908247T4 (en) Sodium glucose co-transporter 1 inhibitors.
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
PH12014501176A1 (en) Anticoagulant reversal agents
MX364220B (en) Methods of treating fibrosis.
WO2014124307A3 (en) Targeted theranostics
EA201600288A1 (en) SUBSTITUTED PHYLALANINE DERIVATIVES
EA201591424A1 (en) METHODS OF TREATMENT OF IRON DEFICIENCY WITH SOLUBLE IRON PYROPHOSPHATE
MX2019010913A (en) Analogs of deutetrabenazine, their preparation and use.
EA201591725A1 (en) SOLID LIPID NANOPARTICLES (II)
MX2015016603A (en) Corticosteroid compositions.
EA201500927A1 (en) SOLID LIPID NANOPARTICLES (I)
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
EA201690709A1 (en) APPLICATION OF ODIPARTSIL IN THE TREATMENT OF MUCOPOLYSACCHARIDOSIS
EP2978434A4 (en) Compositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions
MA38701A1 (en) Pocket and pocket
IN2013CH04330A (en)
UA114965C2 (en) Composition and method for improving mobilizational reserves of the body
AU2014230766A8 (en) Lawn growth-promoting agent and method of using same
TWD177185S (en) electrical connector
TWD177184S (en) electrical connector